Limits...
Combined liver transplantation and sleeve gastrectomy for end-stage liver disease in a bariatric patient: First European case-report

View Article: PubMed Central - PubMed

ABSTRACT

Non-alcoholic Steatohepatitis is the 3rd indication for liver transplantation.

Obese transplanted patients have higher morbidity and mortality rates.

Bariatric surgery decreases morbidity and mortality in obese patients.

Combined liver transplant and sleeve gastrectomy can be safely performed.

Combined liver transplant and sleeve gastrectomy can be safely performed.

No MeSH data available.


BMI Trend.
© Copyright Policy - CC BY-NC-ND
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC5037123&req=5

fig0010: BMI Trend.

Mentions: The patient is currently alive, 5 months after the combined procedure, with normal allograft function, non detectable HCV RNA level, showing significant weight loss (BMI = 29 kg/m2, BMI trend is shown in Fig. 2), no longer requiring insulin or oral hypo-glycemic treatment; she is actually only on immunosuppression drugs (pre and post-LT patient and donor details are showed in Table 1). In addition, there is no evidence of steatosis based on protocol ultrasound performed during the follow-up.


Combined liver transplantation and sleeve gastrectomy for end-stage liver disease in a bariatric patient: First European case-report
BMI Trend.
© Copyright Policy - CC BY-NC-ND
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC5037123&req=5

fig0010: BMI Trend.
Mentions: The patient is currently alive, 5 months after the combined procedure, with normal allograft function, non detectable HCV RNA level, showing significant weight loss (BMI = 29 kg/m2, BMI trend is shown in Fig. 2), no longer requiring insulin or oral hypo-glycemic treatment; she is actually only on immunosuppression drugs (pre and post-LT patient and donor details are showed in Table 1). In addition, there is no evidence of steatosis based on protocol ultrasound performed during the follow-up.

View Article: PubMed Central - PubMed

ABSTRACT

Non-alcoholic Steatohepatitis is the 3rd indication for liver transplantation.

Obese transplanted patients have higher morbidity and mortality rates.

Bariatric surgery decreases morbidity and mortality in obese patients.

Combined liver transplant and sleeve gastrectomy can be safely performed.

Combined liver transplant and sleeve gastrectomy can be safely performed.

No MeSH data available.